PAVmed Newsroom

Express News | Lucid Diagnostics Announces Positive Data From Its Esoguard Be-1 Prospective, International, Multicenter Clinical Validation Study of Esoguard® Esophageal Precancer Testing in a Screening Population

BreakingsJul 2 19:55

12 Health Care Stocks Moving In Monday's After-Market Session

GainersASLAN Pharma (NASDAQ:ASLN) shares moved upwards by 11.9% to $0.4 during Monday's after-market session. The market value of their outstanding shares is at $9.1 million. Biora Therapeutics (NASDA

BenzingaJun 18 04:31

12 Health Care Stocks Moving In Thursday's After-Market Session

GainersVaxart (NASDAQ:VXRT) shares increased by 146.7% to $1.85 during Thursday's after-market session. The market value of their outstanding shares is at $327.1 million. Venus Concept (NASDAQ:VERO) s

BenzingaJun 14 04:31

Express News | PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program With the Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

BreakingsJun 13 19:58

Express News | 4,000TH Firefighter Undergoes Lucid Diagnostics' Esoguard® Esophageal Precancer Testing

BreakingsJun 12 20:05

Ascendiant Maintains PAVmed(PAVM.US) With Buy Rating, Cuts Target Price to $22

Ascendiant analyst Edward Woo maintains $PAVmed(PAVM.US)$ with a buy rating, and adjusts the target price from $26 to $22.According to TipRanks data, the analyst has a success rate of 34.7% and a tota

Futu NewsJun 6 18:31

Express News | Pavmed Inc c/wts 30/04/2024(to pur com) class z: Ascendiant capital markets lowered the target price from $26 to $22.

BreakingsJun 6 12:41

Express News | PAVmed Inc : Ascendiant Capital Markets Cuts Target Price to $22 From $26

BreakingsJun 6 12:39

Analysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO) and PAVmed (PAVM)

TipRanksMay 16 20:10

Analysts' Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM) and PAVmed (PAVM)

TipRanksMay 16 03:40

PAVmed (PAVM) Receives a Buy From Lake Street

TipRanksMay 15 21:05

PAVmed Inc (PAVM) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Financial ...

Yahoo FinanceMay 15 15:02

Earnings Call Summary | PAVmed(PAVM.US) Q1 2024 Earnings Conference

The following is a summary of the PAVmed Inc. (PAVM) Q1 2024 Earnings Call Transcript:Financial Performance:PAVmed concluded Q1 2024 with a cash position of approximately $37.1 million.The average qua

Futu NewsMay 15 03:58 · Conference Call

PAVmed Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Adj. EPS Results.

PAVmed Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Adj. EPS Results.

BenzingaMay 15 01:35

PAVmed Inc Provides Informal Financial Performance Update

TipRanksMay 14 22:52

Reported Late Monday, PAVmed Q1 2024 Adj EPS $(0.99) Beats $(1.67) Estimate, Sales $1.010M Miss $1.053M Estimate

PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.99) per share which beat the analyst consensus estimate of $(1.67) by 40.72 percent. This is a 42.77 percent increase over losses of $(1.73) per s

BenzingaMay 14 15:49

Press Release: PAVmed Provides Business Update and First Quarter 2024 Financial Results

PAVmed Provides Business Update and First Quarter 2024 Financial Results PR Newswire NEW YORK, May 13, 2024 Lucid strengthens balance sheet and secures a July 17, 2024 MolDX pre-submission meeting

Dow JonesMay 14 08:43

10-Q: Quarterly report

SEC announcementMay 14 04:40 · Announcements

Lucid Diagnostics Says EsophaCap Device Recalled Due To Recent Publication Of Serious Device Failures

Lucid Diagnostics Says EsophaCap Device Recalled Due To Recent Publication Of Serious Device Failures

BenzingaMay 9 20:23

Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and...

PR NewswireMay 9 19:49